SCHEMBL5067480

SCHEMBL5067480

COc1cccc(Cc2nc3c(SC)ncnc3s2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.43
MKNK1 Q9BUB5 1/20 0.41
CDC7 O00311 1/20 0.41
DBF4 Q9UBU7 1/20 0.41
GPR52 Q9Y2T5 1/20 0.41
LTA4H P09960 1/20 0.41
HSP90AA1 P07900 1/20 0.39
HSP90AB1 P08238 1/20 0.39
ROCK1 Q13464 1/20 0.38
IDO1 P14902 2/20 0.38
AGXT P21549 2/20 0.38
ADORA2A P29274 2/20 0.38
ADORA2B P29275 2/20 0.38
ADORA1 P30542 2/20 0.38
ADORA3 P0DMS8 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HTT P42858 1/20 0.37
HTR1B P28222 1/20 0.37
CHRM2 P08172 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5064749 0.79 MAPT (0.49) ADORA2AADORA2BADORA1ADORA3HTT
SCHEMBL655669 0.73 DHFR (0.50) DHFRLTA4HIDO1AGXTADORA2A
SCHEMBL2099512 0.69 CHRM2 (0.66) LTA4HIDO1AGXTHTR1BCHRM2
SCHEMBL27681825 0.68 MAPT (0.57) DHFRGPR52LTA4HMEN1KMT2A
Ammonia Solution, Strong SCHEMBL25291856 0.66 LTA4H (0.51) DHFRGPR52LTA4HIDO1AGXT
SCHEMBL5061164 0.66 ALDH1A1 (0.35) MKNK1
SCHEMBL14109370 0.65 GPR52 (0.60) GPR52ROCK1HTT
SCHEMBL5064776 0.65 ADORA3 (0.50) ADORA3HTT
SCHEMBL29194587 0.65 ALDH1A1 (0.68) DHFRLTA4HIDO1AGXTMEN1
SCHEMBL2092574 0.65 LTA4H (0.67) LTA4HIDO1AGXTHTR1BCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269238-A1 Thiazolopyrimidine Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
US-20080269238-A1 Thiazolopyrimidine Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
US-20080269238-A1 Thiazolopyrimidine Derivative TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-10-30 US disclosed
EP-1731523-A1 THIAZOLOPYRIMIDINE DERIVATIVE Takeda Pharmaceutical Company Limited (JP) 2006-12-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269238-A1 Thiazolopyrimidine Derivative FGFR3, FGFR1, ERBB3 DHFR 403/4885MKNK1 2077/4885CDC7 1529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.